Sumatriptan Injection, Solution
Product Images NDC 64380-740

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 64380-740). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sumatriptan-structure (7b0603f0 Ed39 460b 9d7b F19b95006024 01)

FDA Label Image

Device Image (7b0603f0 Ed39 460b 9d7b F19b95006024 02)

FDA Label Image

Image Description (7b0603f0 Ed39 460b 9d7b F19b95006024 03)

Image Description (7b0603f0 Ed39 460b 9d7b F19b95006024 03)
This text provides instructions for using an autoinjector device. It explains that the autoinjector will not work until the cap is removed, emphasizes checking the clarity of the medicine through a transparent window, and instructs to press the blue injection button firmly to start the injection.*
FDA Label Image

Figure A (7b0603f0 Ed39 460b 9d7b F19b95006024 04)

FDA Label Image

Figure B (7b0603f0 Ed39 460b 9d7b F19b95006024 05)

Figure B (7b0603f0 Ed39 460b 9d7b F19b95006024 05)
Description: The text is an indication of a clear liquid before injection. It refers to a figure or image labeled as "Figure B." The liquid appears to be clear and is likely related to medical or scientific content.*
FDA Label Image

Figure C (7b0603f0 Ed39 460b 9d7b F19b95006024 06)

Figure C (7b0603f0 Ed39 460b 9d7b F19b95006024 06)
Blue Plunger Rod fills window after Injection in Figure C.*
FDA Label Image

Figure D (7b0603f0 Ed39 460b 9d7b F19b95006024 07)

FDA Label Image

Figure E (7b0603f0 Ed39 460b 9d7b F19b95006024 08)

FDA Label Image

Figure F (7b0603f0 Ed39 460b 9d7b F19b95006024 09)

FDA Label Image

Figure G (7b0603f0 Ed39 460b 9d7b F19b95006024 10)

FDA Label Image

Figure H (7b0603f0 Ed39 460b 9d7b F19b95006024 11)

Figure H (7b0603f0 Ed39 460b 9d7b F19b95006024 11)
This text describes the movement of the blue plunger after injection, indicating that it moves down and completely fills the flow of medicine. This could be from a medical or instructional illustration showing the proper usage of an injectable device.*
FDA Label Image

Figure I (7b0603f0 Ed39 460b 9d7b F19b95006024 12)

FDA Label Image

Figure J (7b0603f0 Ed39 460b 9d7b F19b95006024 13)

FDA Label Image

Figure K (7b0603f0 Ed39 460b 9d7b F19b95006024 14)

FDA Label Image

Autoinjector-label (7b0603f0 Ed39 460b 9d7b F19b95006024 15)

Autoinjector-label (7b0603f0 Ed39 460b 9d7b F19b95006024 15)
This is a description of Sumatriptan Injection USP in an Autoinjector System with a single-dose autoinjector. Each autoinjector contains 0.5 mL of solution with 8.4 mg of sumatriptan succinate equivalent to 6 mg of sumatriptan. The injection is for subcutaneous use only. The solution has a pH range of approximately 4.2 to 5.3 and an osmolality of 270 - 330 mOsmol. It is sterile, nonpyrogenic, and should be stored between 2° and 30°C (36° and 86°F) while protecting it from light. The product is manufactured by OneSource Specialty Pharma Limited in Bengaluru, India, and distributed by Strides Pharma Inc.*
FDA Label Image

Autoinjector-carton (7b0603f0 Ed39 460b 9d7b F19b95006024 16)

Autoinjector-carton (7b0603f0 Ed39 460b 9d7b F19b95006024 16)
This text contains information on how to use a disposable sumatriptan autoinjector system for injecting Sumatriptan Injection USP for migraine relief. It includes detailed step-by-step instructions on how to use the autoinjector properly, such as pulling the gray cap, straightening the autoinjector, pressing the blue button, and monitoring the injection through the medicine window. It also provides information about the dosage of sumatriptan in the prefilled syringe and advises to keep holding down the autoinjector for 5 seconds after the injection is completed.*
FDA Label Image

Time To Relief Of Cluster Headache From Time Of Injectiona (7b0603f0 Ed39 460b 9d7b F19b95006024 17)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.